Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-19-000504
Filing Date
2019-10-08
Accepted
2019-10-08 12:02:21
Documents
1
Effectiveness Date
2019-10-08

Document Format Files

Seq Description Document Type Size
1 8A_Cert_RLMD.pdf CERT 62089
  Complete submission text file 0001354457-19-000504.txt   86718
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: CERT | Act: 34 | File No.: 001-39082 | Film No.: 191142202
SIC: 2834 Pharmaceutical Preparations